Company news
MedMira Inc. news in 2024
MedMira Inc.'s news releases, calls and decks from 2024, newest first.
MedMira Reports First Quarter Results FY2025
December 30, 2024
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
December 24, 2024
MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
November 28, 2024
MedMira Announces the appointment of Vice President of Commercial Operations
October 3, 2024
Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada
August 13, 2024
MedMira Reports Third Quarter Results FY2024
July 2, 2024
MedMira Announces the Hire of Vice President of Business Development
April 30, 2024
MedMira Reports Second Quarter Results FY2024
April 1, 2024
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
March 13, 2024
CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products
February 1, 2024
Corporate Update on Clinical Evaluation of MedMira's Products
February 1, 2024